DF Dent & Co. Inc. grew its holdings in Danaher Co. (NYSE:DHR) by 56.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 233,548 shares of the conglomerate’s stock after acquiring an additional 83,856 shares during the period. DF Dent & Co. Inc.’s holdings in Danaher were worth $23,047,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also bought and sold shares of the business. Mount Yale Investment Advisors LLC acquired a new position in shares of Danaher during the first quarter worth $103,000. IMS Capital Management acquired a new position in shares of Danaher during the second quarter worth $107,000. BerganKDV Wealth Management LLC acquired a new position in shares of Danaher during the second quarter worth $111,000. Fort L.P. acquired a new position in shares of Danaher during the second quarter worth $119,000. Finally, Braun Bostich & Associates Inc. grew its stake in shares of Danaher by 506.4% during the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock worth $121,000 after purchasing an additional 1,023 shares in the last quarter. Institutional investors and hedge funds own 76.95% of the company’s stock.

In related news, CFO Daniel L. Comas sold 77,407 shares of the business’s stock in a transaction on Thursday, July 26th. The shares were sold at an average price of $103.93, for a total value of $8,044,909.51. Following the completion of the sale, the chief financial officer now directly owns 135,218 shares of the company’s stock, valued at $14,053,206.74. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Robert S. Lutz sold 14,555 shares of the business’s stock in a transaction on Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the completion of the sale, the senior vice president now directly owns 18,044 shares of the company’s stock, valued at $1,875,312.92. The disclosure for this sale can be found here. Over the last three months, insiders sold 299,961 shares of company stock valued at $30,619,691. 11.90% of the stock is owned by corporate insiders.

Shares of DHR opened at $107.42 on Friday. Danaher Co. has a 1-year low of $83.81 and a 1-year high of $107.54. The firm has a market capitalization of $74.03 billion, a P/E ratio of 24.43, a P/E/G ratio of 2.02 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.50 and a quick ratio of 1.07.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The firm had revenue of $4.98 billion during the quarter, compared to analysts’ expectations of $4.91 billion. During the same period in the previous year, the company earned $0.99 earnings per share. Danaher’s quarterly revenue was up 10.4% compared to the same quarter last year. sell-side analysts predict that Danaher Co. will post 4.49 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be given a $0.16 dividend. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.60%. Danaher’s dividend payout ratio (DPR) is presently 15.88%.

DHR has been the subject of a number of analyst reports. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $113.00 target price for the company in a research note on Thursday, May 17th. ValuEngine upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Thursday, July 12th. Morgan Stanley boosted their target price on shares of Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a research note on Friday, July 20th. Finally, Royal Bank of Canada boosted their target price on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $109.20.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Article: How to Track your Portfolio in Google Finance

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.